Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KX7105 vs diphenhydramine for acute urticaria
CTR20212731Phase 3Completed
- Sponsor
- Baiyu Pharmaceutical
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of KX7105 in acute urticaria, sponsored by Baiyu Pharmaceutical. Started Oct 2021; status: completed.
02
Drugs
KX7105
03
Conditions
acute urticaria
Beyond the preview
Go deeper on CTR20212731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212731.